After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Understand when to choose target date retirement over index and why the choice matters for long-term planning. This intro explains the core considerations for a simple, informed decision.
25,703 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
International small caps have surged about 35% over the past year as value and profitability themes take hold in deve...
Bitcoin eyes a pivotal test near the $58,000 zone as ETF-driven demand falters. If that support cracks, bitcoin still...
Palantir surged about 9% after announcing a Sovereign-AI partnership with NVIDIA, aimed at secure, air-gapped governm...
Emily Blunt just pocketed $15 million for her newest film, boosting her reported fortune. This analysis looks at how ...
The June payroll gain came in at 57,000, with the unemployment rate slipping to 4.2%. Revisions to April and May pain...
Trump's stop at the Theodore Roosevelt Presidential Library highlights how cultural investments can ripple through lo...
Meta is weighing a bold bet to embed real-money wagering in its social apps. The move could unlock new revenue but ra...
Remote work holds steady around 22% of US workers in early 2026, defying headlines of a mass office return. New data ...
MicroStrategy is monetizing BTC to back dividends and bolster liquidity, draining a portion of its planned sale capac...
Internal documents reveal OpenAI posted $21B in losses on $13B in revenue, signaling a costly push to scale AI at bre...
Anthropic’s IPO path is shaping AI headlines, but patient investors can still win by focusing on established tech gia...